StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Non-Current Financial Debts by Quarter

Non-Current Financial Debts ($M)

QuarterlyAnnual

Novartis Non-Current Financial Debts: $36,699M in Q3 2026, up 62.4% from a year earlier.

Latest, Q3 2026
36,699
Period ended Sep 30, 2026
Change on a year earlier
+62.4%
22,598 in Q3 2025
History
32 quarters
Since Q4 2018
Sources
24
Documents cited below

Where the Q3 2026 figure comes from

“|| Financial debts | 36 699 | 27 935”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-Current Financial Debts ($M)Year on yearSource
Q3 2026Sep 30, 202636,699+62.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202637,489+66.8%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202637,447+72.8%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202527,935+30.7%Novartis Form 6-K (0001114448-26-000014) ↗
Q3 2025Sep 30, 202522,598-4.9%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202522,470+14.3%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202521,666+26.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202421,366+15.9%Novartis Form 6-K (0001114448-25-000003) ↗
Q3 2024Sep 30, 202423,750+31.4%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202419,663+7.7%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202417,191-15.7%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202318,436-8.9%Novartis Form 6-K (0001370368-24-000022) ↗
Q3 2023Sep 30, 202318,068-8.4%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202318,259-17.9%Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 202320,396-10.5%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 202220,244-11.6%Novartis Form 6-K (0001370368-23-000068) ↗

Cite this data

StockData. (2026). Novartis Non-Current Financial Debts ($M), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-lt-debt

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.